New data backs promise of long-acting Sanofi insulin
PARIS (Reuters) - An improved version of Sanofi's diabetes drug Lantus is better than the old one at controlling blood sugar levels and comes with few...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/S235OuXNFpA/story01.htm
This comment has been removed by a blog administrator.
ReplyDelete